# OSR Health, Inc. (OSRHW) — delisting/forced [announced]
Source: sec.gov · situation sit_30fb2f45a79d3d986735 · public 6757941945448558046 · retrieved 2026-08-20T13:43:35.816Z

## Overview
OSR Health, Inc. is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness through subsidiaries engaged in immuno-oncology, regenerative biologics, and medical device technologies.

On August 19, 2026, OSR Health, Inc. received a Staff Determination Letter from Nasdaq notifying the company that its common stock and warrants are subject to delisting from The Nasdaq Capital Market due to failure to maintain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share. Trading in the company's common stock (OSRH) and warrants (OSRHW) will be suspended at the opening of business on August 26, 2026. Nasdaq will file a Form 25-NSE to remove the company's securities from listing and registration. The company intends to request a hearing before a Nasdaq Hearings Panel by August 26, 2026, though a timely hearing request will not stay the trading suspension but is expected to stay the final delisting pending the Panel's decision.

## Terms
- Counterparty: The Nasdaq Stock Market LLC

## Key dates
- Announced 2026-08-19 · Expected close 2026-08-26

## Timeline
- 2026-08-19 · 8-K (0001213900-26-091756): 8-K - OSR Health, Inc. — *OSR Health, Inc. is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness through subsidiaries engaged in immuno-oncology, regenerative biologics, and medical device technologies.* On August 19, 2026, OSR Health, Inc. received a Staff Determination Letter from Nasdaq notifying the company that its common stock and warrants are subject to delisting from The Nasdaq Capital Market due to failure to maintain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share. Trading in the company's common stock (OSRH) and warrants (OSRHW) will be suspended at the opening of business on August 26, 2026. Nasdaq will file a Form 25-NSE to remove the company's securities from listing and registration. The company intends to request a hearing before a Nasdaq Hearings Panel by August 26, 2026, though a timely hearing request will not stay the trading suspension but is expected to stay the final delisting pending the Panel's decision.
  https://www.sec.gov/Archives/edgar/data/1840425/0001213900-26-091756.txt

## Citations
- 0001213900-26-091756 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026091756